Download Files:
Products Details
Product Description
– KRAS G12C inhibitor 39 is a potent inhibitor of KRAS G12C. KRas is a highly attractable target of the pharmaceutical industry for cancer research. KRAS G12C inhibitor 39 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2019099524A1, compound 494)[1].
Web ID
– HY-143592
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C37H43N9O2
References
– [1]James F. Blake, et al. Kras g12c inhibitors. Patent WO2019099524A1.
CAS Number
– 2326522-16-9
Molecular Weight
– 645.80
SMILES
– N#CC[C@@H]1N(C(/C=C/C2=CN(C)N=C2)=O)CCN(C3=C4C(CN(C5=C6C(C)=CC=CC6=CC=C5)CC4)=NC(OC[C@H]7N(C)CCC7)=N3)C1
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Ras
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
